Patents by Inventor Robert L. Engler

Robert L. Engler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of altering cardiac cell phenotype
    Publication number: 20030072744
    Abstract: Methods for improving or maintaining cardiac function in patients are disclosed. The methods include the stimulation of heart muscle regeneration, the treatment of patients with congestive heart failure and the prevention of organ transplant rejection. Methods are also disclosed for the treatment of patients after myocardial infarction and/or patients with congestive heart failure by adenovirus-mediated delivery of peptides, including, but not limited to, NKX-2.5, MEF2, GATA4, BCL-2, HGH, and Fas ligand, that alter the phenotype of cells in the heart.
    Type: Application
    Filed: September 18, 2002
    Publication date: April 17, 2003
    Applicant: COLLATERAL THERAPEUTICS
    Inventor: Robert L. Engler
  • Methods of altering cardiac cell phenotype
    Publication number: 20010016193
    Abstract: Methods for improving or maintaining cardiac function in patients are disclosed. The methods include the stimulation of heart muscle regeneration, the treatment of patients with congestive heart failure and the prevention of organ transplant rejection. Methods are also disclosed for the treatment of patients after myocardial infarction and/or patients with congestive heart failure by adenovirus-mediated delivery of peptides, including, but not limited to, NKX-2.5, MEF2, GATA4, BCL-2, HGH, and Fas ligand, that alter the phenotype of cells in the heart.
    Type: Application
    Filed: December 19, 2000
    Publication date: August 23, 2001
    Inventor: Robert L. Engler